Related Experiment Video
Updated: Jul 23, 2025

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
New insight into the causes, consequences, and correction of hematopoietic stem cell aging
Els Mansell1, Dawn S Lin2, Stephen J Loughran3
1Erasmus MC Hematology, Rotterdam, The Netherlands; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.
Insights
Hematopoietic stem cells (HSCs) aging leads to functional decline and disease predisposition. This review explores inflammation and niche factors in HSC aging and potential therapeutic strategies.
Area of Science:
- Hematology
- Stem Cell Biology
- Aging Research
Background:
- Aging hematopoietic stem cells (HSCs) exhibit lineage bias, reduced function, and altered molecular profiles.
- Key molecular changes include metabolic dysregulation, increased inflammation, and impaired DNA repair in aged HSCs.
- Cellular aging of HSCs contributes to age-related hematologic diseases like anemia, immune compromise, and cancer.
Purpose of the Study:
- To explore the biological basis of age-related decline in HSC fitness.
- To discuss the roles of inflammation and the stem cell niche in HSC aging.
- To speculate on therapeutic strategies for age-related hematopoietic dysfunction.
Main Methods:
- Review of recent insights from leading laboratories.
- Focus on inflammatory and niche-driven mechanisms of stem cell aging.
- Discussion of potential interventions for age-related HSC decline.
Main Results:
- Aged HSCs show distinct molecular and functional deficits.
- Both intrinsic cellular factors and extrinsic niche interactions drive HSC aging.
- Inflammatory signaling and niche alterations are critical contributors to HSC aging.
Conclusions:
- Age-related decline in HSC function is multifactorial, involving inflammation and niche changes.
- Understanding these mechanisms may reveal therapeutic targets to improve hematopoietic health in aging individuals.
- Further research into HSC aging could lead to strategies to prevent or reverse age-related hematopoietic disorders.
Abstract:
Aging of hematopoietic stem cells (HSCs) is characterized by lineage bias, increased clonal expansion, and functional decrease. At the molecular level, aged HSCs typically display metabolic dysregulation, upregulation of inflammatory pathways, and downregulation of DNA repair pathways. Cellular aging of HSCs, driven by cell-intrinsic and cell-extrinsic factors, causes a predisposition to anemia, adaptive immune compromise, myelodys, plasia, and malignancy. Most hematologic diseases are strongly associated with age. But what is the biological foundation for decreased fitness with age? And are there therapeutic windows to resolve age-related hematopoietic decline? These questions were the focus of the International Society for Experimental Hematology (ISEH) New Investigator Committee Fall 2022 Webinar. This review touches on the latest insights from two leading laboratories into inflammatory- and niche-driven stem cell aging and includes speculation on strategies to prevent or correct age-related decline in HSC function.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Hematopoiesis
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Lineage Commitment

